A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

Previous studies in experimental autoimmune encephalomyelitis (EAE) models have shown that some probiotic bacteria beneficially impact the development of this experimental disease. Here, we tested the therapeutic effect of two commercial multispecies probiotics—Lactibiane iki and Vivomixx—on the cli...

Full description

Bibliographic Details
Main Authors: Laura Calvo-Barreiro, Herena Eixarch, Manuel Ponce-Alonso, Mireia Castillo, Rafael Lebrón-Galán, Leyre Mestre, Carmen Guaza, Diego Clemente, Rosa del Campo, Xavier Montalban, Carmen Espejo
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cells
Subjects:
gut microbiota
probiotics
immune regulation
experimental autoimmune encephalomyelitis
multiple sclerosis
adaptive immunity
Online Access:https://www.mdpi.com/2073-4409/9/4/906

Internet

https://www.mdpi.com/2073-4409/9/4/906

Similar Items